APRETUDE Trademark

Trademark Overview


On Tuesday, November 5, 2019, a trademark application was filed for APRETUDE with the United States Patent and Trademark Office. The USPTO has given the APRETUDE trademark a serial number of 88680774. The federal status of this trademark filing is REGISTERED as of Tuesday, October 27, 2020. This trademark is owned by Glaxo Group Limited. The APRETUDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment and prevention of HIV and AIDS; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
apretude

General Information


Serial Number88680774
Word MarkAPRETUDE
Filing DateTuesday, November 5, 2019
Status700 - REGISTERED
Status DateTuesday, October 27, 2020
Registration Number6183321
Registration DateTuesday, October 27, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment and prevention of HIV and AIDS; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVIIV HEALTHCARE UK (NO.3) LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type77 - NOT AVAILABLE
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, August 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 12, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 27, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 6, 2020ASSIGNED TO LIE
Wednesday, July 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 14, 2020NON-FINAL ACTION E-MAILED
Tuesday, January 14, 2020NON-FINAL ACTION WRITTEN
Monday, January 13, 2020ASSIGNED TO EXAMINER
Wednesday, November 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 8, 2019NEW APPLICATION ENTERED